ARCA Biopharma Inc (NASDAQ:ABIO)

1.65
Delayed Data
As of Feb 16
 +0.005 / +0.30%
Today’s Change
1.05
Today|||52-Week Range
2.76
+22.22%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization7.0K7.0K7.0K7.0K
 
 
 
 
 
 
Operating ExpensesGross Income-7.0K-7.0K-7.0K-7.0K
 
 
 
 
 
General Expenses4.3M4.4M5.6M4.5M
 
 
 
 
 
Research And Development3.1M3.2M4.5M3.5M
 
 
 
 
 
Total Operating Expenses4.3M4.4M5.6M4.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.3M-4.4M-5.6M-4.5M
 
 
 
 
 
Other Expenses0.00-2.0K-2.0K-2.0K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.2M-4.3M-5.5M-4.4M
 
 
 
 
 
Net Income-4.2M-4.3M-5.5M-4.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS9.1M9.1M9.3M11.5M
 
 
 
 
 
Shares To Calculate EPS Diluted9.1M9.1M9.3M11.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.48-$0.59-$0.39
 
 
 
 
 
EPS Diluted-$0.47-$0.48-$0.59-$0.39